Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes with Radiation and PD-1 Blockade (vol 116, pg 894, 2023)

被引：0
|
作者：
Zhuang, Yuan [1 ]
Wang, Yuzi [1 ,2 ]
Liu, Chang [1 ]
Li, Sihan [1 ]
Du, Shuyan [3 ]
Li, Guang [1 ]
机构：
[1] China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China
[2] Univ Tsukuba, Proton Med Res Ctr, Tsukuba, Japan
[3] China Med Univ, Hosp 1, Dept Cent Lab, Shenyang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 119卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2024.02.058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1032 / 1033
页数：2
相关论文
共 50 条
  • [41] Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade
    Holzgruber, Julia
    Martins, Christina
    Kulcsar, Zsofi
    Duplaine, Alexandra
    Rasbach, Erik
    Migayron, Laure
    Singh, Praveen
    Statham, Edith
    Landsberg, Jennifer
    Boniface, Katia
    Seneschal, Julien
    Hoetzenecker, Wolfram
    Berdan, Emma L.
    Sui, Shannan Ho
    Ramsey, Matthew R.
    Barthel, Steven R.
    Schatton, Tobias
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [42] PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance (vol 20, pg 1231, 2019)
    Verma, Vivek
    Shrimali, Rajeev K.
    Ahmad, Shamim
    Dai, Winjie
    Wang, Hua
    Lu, Sumin
    Nandre, Rahul
    Gaur, Pankaj
    Lopez, Jose
    Sade-Feldman, Moshe
    Yizhak, Keren
    Bjorgaard, Stacey L.
    Flaherty, Keith T.
    Wargo, Jennifer A.
    Boland, Genevieve M.
    Sullivan, Ryan J.
    Getz, Gad
    Hammond, Scott A.
    Tan, Ming
    Qi, Jingjing
    Wong, Phillip
    Merghoub, Taha
    Wolchok, Jedd
    Hacohen, Nir
    Janik, John E.
    Mkrtichyan, Mikayel
    Gupta, Seema
    Khleif, Samir N.
    NATURE IMMUNOLOGY, 2019, 20 (11) : 1555 - 1555
  • [43] NEOADJUVANT PD-1 BLOCKADE INDUCES T CELL AND CDC1 ACTIVATION BUT FAILS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR ASSOCIATED MACROPHAGES IN RECURRENT GLIOBLASTOMA
    Lee, Alexander
    Sun, Lu
    Mochizuki, Aaron
    Reynoso, Jeremy
    Orpilla, Joey
    Chow, Frances
    Kienzler, Jenny
    Everson, Richard
    Nathanson, David
    Liau, Linda
    Cloughesy, Timothy
    Hugo, Willy
    Prins, Robert
    NEURO-ONCOLOGY, 2021, 23 : 101 - 101
  • [44] Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
    Alexander H. Lee
    Lu Sun
    Aaron Y. Mochizuki
    Jeremy G. Reynoso
    Joey Orpilla
    Frances Chow
    Jenny C. Kienzler
    Richard G. Everson
    David A. Nathanson
    Steven J. Bensinger
    Linda M. Liau
    Timothy Cloughesy
    Willy Hugo
    Robert M. Prins
    Nature Communications, 12
  • [45] Cyclin dependent kinase 9 (CDK9) inhibition increased efficacy of programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma (HCC) through decreasing programmed death-ligand 1 (PD-L1) expression
    Chen, Ching-Tso
    Shao, Yu-Yun
    Hsu, Hung-Wei
    Wo, Rita R.
    Wang, Han-Yu
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
    Lee, Alexander H.
    Sun, Lu
    Mochizuki, Aaron Y.
    Reynoso, Jeremy G.
    Orpilla, Joey
    Chow, Frances
    Kienzler, Jenny C.
    Everson, Richard G.
    Nathanson, David A.
    Bensinger, Steven J.
    Liau, Linda M.
    Cloughesy, Timothy
    Hugo, Willy
    Prins, Robert M.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [47] CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer
    Li, Yi
    Zhang, Hui
    Li, Qin
    Zou, Pingjin
    Huang, Xingxiang
    Wu, Chihua
    Tan, Li
    CANCER LETTERS, 2020, 495 : 12 - 21
  • [48] B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade
    Kim, Sangwoo S.
    Shen, Sarek
    Miyauchi, Sayuri
    Sanders, P. Dominick
    Franiak-Pietryga, Ida
    Mell, Loren
    Gutkind, J. Silvio
    Cohen, Ezra E. W.
    Califano, Joseph A.
    Sharabi, Andrew B.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3345 - 3359
  • [49] BET bromodomain inhibition synergizes with PD-1 blockade to facilitate anti-tumor response in Kras-mutant non-small cell lung cancer
    Adeegbe, Dennis O.
    Liu, Shengwu
    Bowden, Michaela
    Hammerman, Peter S.
    Bradner, James E.
    Rustgi, Anil K.
    Bass, Adam J.
    Freeman, Gordon J.
    Chen, Huawei
    Wong, Kwok-Kin
    CANCER RESEARCH, 2018, 78 (13)
  • [50] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer (vol 2019, 2989048, 2019)
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
12345